The research team found that there was an upregulation in IL-10, Osteopontin, MMP14, VEGF, TGF β, and CCL18 in samples containing both human stem cell derived microglial cells with human glioma cells, as opposed to samples containing human glioma cells alone (40). Here, CCL18 is linked to central nervous system cancer.